| Name | Tops Markets, Llc |
|---|---|
| Organization Name | Tops Markets Llc |
| Location | 700 1st North Street, Syracuse, New York 13208 |
| Type | Pharmacy |
| Phone | (315) 470-0988 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
SNM is calling on Congress to support the Consistency, Accuracy, Responsibility and Excellence in Medical Imaging and Radiation Therapy Act (CARE bill), which would ensure that states set minimum education and credentialing standards for nuclear medicine technologists. The bill (H.R. 3652) was introduced Sept. 28 in the U.S. House of Representatives by Rep. John Barrow (D-Ga.).
The population of aged persons worldwide is expanding rapidly, and it is becoming increasingly clear that there are many different diseases that affect the minds of these individuals. Researchers at the University of Kentucky are breaking new ground in the ongoing project of identifying and defining those diseases most likely to affect an aged population.
Seattle Genetics, Inc. and Millennium: The Takeda Oncology Company, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, today announced positive results from the pivotal trial of single-agent brentuximab vedotin (SGN-35) in relapsed or refractory Hodgkin lymphoma. Brentuximab vedotin is an antibody-drug conjugate targeted to CD30, a defining marker of Hodgkin lymphoma.
Researchers from Case Western Reserve University in Cleveland have discovered that populating the gastrointestinal (GI) tracts of mice with Bacteroides species producing a specific enzyme helps protect the good commensal bacteria from the harmful effects of antibiotics.
› Verified 7 days ago
| NPI Number | 1649517111 |
| Organization Name | TOPS MARKETS LLC |
| Doing Business As | TOPS PHARMACY |
| Type | Pharmacy |
| Address | 700 1st North St, Syracuse, NY 13208 |
| Phone Number | 315-470-0988 |
News Archive
SNM is calling on Congress to support the Consistency, Accuracy, Responsibility and Excellence in Medical Imaging and Radiation Therapy Act (CARE bill), which would ensure that states set minimum education and credentialing standards for nuclear medicine technologists. The bill (H.R. 3652) was introduced Sept. 28 in the U.S. House of Representatives by Rep. John Barrow (D-Ga.).
The population of aged persons worldwide is expanding rapidly, and it is becoming increasingly clear that there are many different diseases that affect the minds of these individuals. Researchers at the University of Kentucky are breaking new ground in the ongoing project of identifying and defining those diseases most likely to affect an aged population.
Seattle Genetics, Inc. and Millennium: The Takeda Oncology Company, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, today announced positive results from the pivotal trial of single-agent brentuximab vedotin (SGN-35) in relapsed or refractory Hodgkin lymphoma. Brentuximab vedotin is an antibody-drug conjugate targeted to CD30, a defining marker of Hodgkin lymphoma.
Researchers from Case Western Reserve University in Cleveland have discovered that populating the gastrointestinal (GI) tracts of mice with Bacteroides species producing a specific enzyme helps protect the good commensal bacteria from the harmful effects of antibiotics.
› Verified 7 days ago
News Archive
SNM is calling on Congress to support the Consistency, Accuracy, Responsibility and Excellence in Medical Imaging and Radiation Therapy Act (CARE bill), which would ensure that states set minimum education and credentialing standards for nuclear medicine technologists. The bill (H.R. 3652) was introduced Sept. 28 in the U.S. House of Representatives by Rep. John Barrow (D-Ga.).
The population of aged persons worldwide is expanding rapidly, and it is becoming increasingly clear that there are many different diseases that affect the minds of these individuals. Researchers at the University of Kentucky are breaking new ground in the ongoing project of identifying and defining those diseases most likely to affect an aged population.
Seattle Genetics, Inc. and Millennium: The Takeda Oncology Company, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, today announced positive results from the pivotal trial of single-agent brentuximab vedotin (SGN-35) in relapsed or refractory Hodgkin lymphoma. Brentuximab vedotin is an antibody-drug conjugate targeted to CD30, a defining marker of Hodgkin lymphoma.
Researchers from Case Western Reserve University in Cleveland have discovered that populating the gastrointestinal (GI) tracts of mice with Bacteroides species producing a specific enzyme helps protect the good commensal bacteria from the harmful effects of antibiotics.
› Verified 7 days ago
Central New York Medical Products I Type: DME Supplier - Customized Equipment Location: 749 W Genesee St, Syracuse, New York 13204 Phone: (315) 428-9945 | |
Coram Healthcare Corporation Of Gre Type: Medicare Supplier Location: 2949 Erie Blvd E, Syracuse, New York 13224 Phone: (315) 425-8028 | |
Cvs Pharmacy #11238 Type: Pharmacy Location: 300 Gifford St, Syracuse, New York 13204 Phone: (315) 471-4139 | |
Cvs Pharmacy #17390 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 3657 W Genesee St, Syracuse, New York 13219 Phone: (315) 233-0601 | |
Rite Aid Pharmacy 10756 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1820 Teall Ave, Syracuse, New York 13206 Phone: (315) 437-1531 |